Abstracts Archive - Page 425 of 1683 - ATC Abstracts

2020 American Transplant Congress
Social Support in the Peri-Liver Transplant Period Affects Post-Transplant Survival, Rejection Rate and Length of Stay
T. Ashraf¹, V. Mendiratta², S. Gill¹, A. Abdelwahab³, D. Moonka², S. Jafri²
¹Internal Medicine, Henry Ford Hospital, Detroit, MI, ²Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, ³Wayne State University, Detroit, MI
*Purpose: Although social support is a key component of the pre-transplant evaluation, it’s effect on post-transplant outcomes remains understudied. The purpose of this study was…
2020 American Transplant Congress
Predicting the Safe Use of Deceased after Circulatory Death Liver Allografts in Primary Sclerosing Cholangitis
V. Fleetwood, A. Gracon, D. Aufhauser, C. Papageorge, K. Janek, G. Leverson, D. Foley, J. Mezrich, A. D'Alessandro, L. Fernandez, D. Al-Adra
Department of Transplantation, University of Wisconsin, Madison, WI
*Purpose: The use of deceased after circulatory donation (DCD) liver allografts in patients with primary sclerosing cholangitis (PSC) is controversial given the already-increased risk of…
2020 American Transplant Congress
Sarcopenia Predicts Worse Outcomes in Pediatric Liver Transplant Patients
J. M. Boster¹, L. P. Browne², Z. Pan³, W. Zhou³, S. S. Sundaram¹
¹Pediatric Gastroenterology, Hepatology & Nutrition, Children’s Hospital Colorado, University of Colorado, Aurora, CO, ²Radiology, Children’s Hospital Colorado, University of Colorado, Aurora, CO, ³University of Colorado School of Medicine, Aurora, CO
*Purpose: Sarcopenia, or decreased muscle mass and function, is prevalent in adults with end-stage liver disease and negatively affects outcomes in liver transplantation (LT). Sarcopenia,…
2020 American Transplant Congress
A Population-Based Analysis of Hepatocellular Carcinoma in Children: Identifying Optimal Surgical Treatment
I. A. Ziogas¹, L. K. Matsuoka¹, M. I. Montenovo¹, M. Izzy¹, D. J. Benedetti¹, H. N. Lovvorn III², L. A. Gillis¹, S. P. Alexopoulos¹
¹Vanderbilt University Medical Center, Nashville, TN, ²Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN
*Purpose: Hepatocellular carcinoma (HCC) constitutes 0.5% of childhood malignancies and exhibits poor prognosis. Complete tumor extirpation either by partial liver resection (LR) or liver transplantation…
2020 American Transplant Congress
New Concept of Liver Transplatation in Pediatric Patient – Up Side Down Metod
P. Dubska, L. Janousek, J. Chlupac, M. Kocik, J. Fronek
Transplantation Surgery, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
*Purpose: Liver transplantation (LTx) in pediatrics has become an accepted modality for treatment in end-stage liver disease and irreversible acute liver failure. Left lateral segment…
2020 American Transplant Congress
Hypernatremia Predicts Waitlist Death and Deterioration, but Not Post-Transplant Outcomes in Pediatric Liver Transplant Candidates
L. Thalji¹, N. Thalji², S. Ibrahim³, J. Heimbach², P. Kamath⁴, D. Haile¹, D. Kor¹
¹Anesthesiology, Mayo Clinic, Rochester, MN, ²Surgery, Mayo Clinic, Rochester, MN, ³Pediatric Gastroenterology, Mayo Clinic, Rochester, MN, ⁴Gastroenterology, Mayo Clinic, Rochester, MN
*Purpose: Pre-transplant hypernatremia has been shown to predict post-transplant mortality in adult liver transplant (LT) recipients. The effects of hypernatremia in children, however, remain unexplored.…
2020 American Transplant Congress
Safety and Efficacy of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis
D. E. Ecabert, C. Pham, B. J. Pierce, W. L. Musick
Houston Methodist Hospital, Houston, TX
*Purpose: Cytomegalovirus (CMV) is the most common viral infection after solid organ transplant (SOT) and is associated with significant morbidity and mortality. Valganciclovir (VGCV) is…
2020 American Transplant Congress
Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population
S. Suh, Y. Choi
Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of
*Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…
2020 American Transplant Congress
Liver Transplantation for Pediatric Genetic and Metabolic Liver Disease: A Single-Center Experience
S. Hassan¹, K. Mysore¹, D. N. Cerminara², K. E. Hosek³, M. Faraone⁴, R. Sigereddi⁵, R. Ackah⁵, A. Rana⁶, J. Goss⁶, T. Galvan⁶
¹Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ²Pharmacy, Texas Children's Hospital, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ³Outcomes and Impact Service, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁴Department of Surgery, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁵Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, ⁶Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX
*Purpose: Pediatric liver transplantation (LT) is an established treatment for a myriad of liver diseases most notably biliary atresia and urea cycle defects. In the…
2020 American Transplant Congress
Limited Differences in Infectious Complications of Pediatric Liver Transplant between Hepatoblastoma and Non-Hepatoblastoma Patients
H. Hendricks, A. Lane, J. Geller, A. Bondoc, A. Taylor, G. Paulsen, S. Hirth, S. Blum, G. Tiao, L. Danziger-Isakov
Cincinnati Children's Hosp Med Cntr, Cincinnati, OH
*Purpose: Pediatric liver transplantation (pLTX) has become a part of treatment for Hepatoblastoma (HB). The incidence and characterization of infectious events (IE) has not been…